Comparison of tulathromycin versus enrofloxacin for the treatment of bovine respiratory disease following metaphylaxis in U.S. commercial feedlots
American Association of Bovine Practitioners Conference Proceedings · 28.04.2026 · 58 (2) · 230
DOI: 10.21423/aabppro20259414 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Association of Bovine Practitioners Conference Proceedings, online erschienen am 28.04.2026. Verfasst von Shane Terrell und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Macrolide antimicrobial drugs are commonly used for treatment and control of bovine respiratory disease (BRD). The objective of this study was to compare the efficacy of tulathromycin and enrofloxacin for treatment of BRD, following metaphylaxis with tulathromycin.
Zitieren
APA
Terrell, S., Lowe, J., Jobman, E., Thomson, D., & Newberry, J. (2026). Comparison of tulathromycin versus enrofloxacin for the treatment of bovine respiratory disease following metaphylaxis in U.S. commercial feedlots. American Association of Bovine Practitioners Conference Proceedings, 58(2), 230. https://doi.org/10.21423/aabppro20259414
Vancouver
Terrell S, Lowe J, Jobman E, Thomson D, Newberry J. Comparison of tulathromycin versus enrofloxacin for the treatment of bovine respiratory disease following metaphylaxis in U.S. commercial feedlots. American Association of Bovine Practitioners Conference Proceedings. 2026;58(2):230. doi:10.21423/aabppro20259414
BibTeX
@article{Terrell2026,
author = {Terrell, Shane and Lowe, James and Jobman, Erin and Thomson, Dan and Newberry, Jessica},
title = {Comparison of tulathromycin versus enrofloxacin for the treatment of bovine respiratory disease following metaphylaxis in U.S. commercial feedlots},
journal = {American Association of Bovine Practitioners Conference Proceedings},
year = {2026},
volume = {58},
number = {2},
pages = {230},
doi = {10.21423/aabppro20259414}
}
EUVIMED